Abstract
Scope:
Inflammatory response of macrophages is regulated by vitamin E forms. The long-chain metabolite α-13'-carboxychromanol (α-13'-COOH) is formed by hepatic α-tocopherol (α-TOH) catabolism and acts as a regulatory metabolite via pathways that are different from its metabolic precursor.
Methods and results:
Using semisynthetically-derived α-13'-COOH we profiled its action on LPS-induced expression of pro- and anti-inflammatory genes using RT-qPCR and of key proteins by Western blotting. Effects on inflammatory response were assessed by measuring production of nitric oxide and prostaglandin (PG) E2 , PGD2 , and PGF2α. α-13'-COOH inhibits proinflammatory pathways in LPS-stimulated RAW264.7 macrophages more efficiently than α-TOH. Profiling inflammation-related genes showed significant blocking of interleukin (Il)1β by the metabolite and its precursor as well, while upregulation of Il6 was not impaired. However, induction of Il10, cyclooxygenase 2 (Cox2) and inducible nitric oxide synthase (iNos) by LPS and consequently the formation of nitric oxide and PG was significantly reduced by α-13'-COOH. Interestingly, α-13'-COOH acted independently from translocation of NFκB subunit p65.
Conclusion:
Our study sheds new light on the mode of action of α-TOH on the inflammatory response in macrophages, which may be mediated in vivo at least in part by its metabolite α-13'-COOH. Our data show that α-13'-COOH is a potent anti-inflammatory molecule.
Keywords:
Inflammation; Inflammatory response; Macrophage activation; Macrophages; α-13’-COOH; α-Tocopherol.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Active Transport, Cell Nucleus / drug effects
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / metabolism*
-
Benzopyrans / metabolism*
-
Cyclooxygenase 2 / chemistry
-
Cyclooxygenase 2 / genetics
-
Cyclooxygenase 2 / metabolism
-
Dinoprost / antagonists & inhibitors
-
Dinoprost / metabolism
-
Dinoprostone / antagonists & inhibitors
-
Dinoprostone / metabolism
-
Fatty Acids / metabolism*
-
Gene Expression Regulation* / drug effects
-
Immunomodulation* / drug effects
-
Interleukin-10 / antagonists & inhibitors
-
Interleukin-10 / genetics
-
Interleukin-10 / metabolism
-
Interleukin-1beta / antagonists & inhibitors
-
Interleukin-1beta / genetics
-
Interleukin-1beta / metabolism
-
Lipopolysaccharides / antagonists & inhibitors
-
Lipopolysaccharides / pharmacology
-
Macrophage Activation* / drug effects
-
Macrophages / drug effects
-
Macrophages / immunology
-
Macrophages / metabolism*
-
Mice
-
Nitric Oxide / antagonists & inhibitors
-
Nitric Oxide / metabolism
-
Nitric Oxide Synthase Type II / antagonists & inhibitors
-
Nitric Oxide Synthase Type II / genetics
-
Nitric Oxide Synthase Type II / metabolism
-
Prostaglandin D2 / antagonists & inhibitors
-
Prostaglandin D2 / metabolism
-
RAW 264.7 Cells
-
Transcription Factor RelA / metabolism
-
alpha-Tocopherol / analogs & derivatives*
-
alpha-Tocopherol / metabolism
Substances
-
13'-(6-hydroxy-2,5,7,8,-tetramethylchroman-2-yl)-2,6,10-trimethyltridecanoic acid
-
Anti-Inflammatory Agents, Non-Steroidal
-
Benzopyrans
-
Fatty Acids
-
IL10 protein, mouse
-
IL1B protein, mouse
-
Interleukin-1beta
-
Lipopolysaccharides
-
Rela protein, mouse
-
Transcription Factor RelA
-
Interleukin-10
-
Nitric Oxide
-
Dinoprost
-
Nitric Oxide Synthase Type II
-
Nos2 protein, mouse
-
Ptgs2 protein, mouse
-
Cyclooxygenase 2
-
alpha-Tocopherol
-
Dinoprostone
-
Prostaglandin D2